Cancer Imaging System Market: Introduction
Cancer imaging system is a diagnostic tool used for the detection of cancer types by locating the site of cancer cells and also providing detailed information and extent of the disease and its structural changes.
Cancer imaging systems enable the detection of tumor and its associated complications, which further resulting in the evaluation of the post therapeutic treatment by specialists. Major cancer tumors are likely to be treated at an early stage if diagnosed properly. This is likely to boost the demand for cancer imaging systems.
As per GLOBOCAN data, in December 2020, the cancer burden has increased to 19.3 million cases and 10 million cancer deaths worldwide. Presence of companies across the globe is offering cancer imaging system for standard diagnosis for cancer treatment.
Key Drivers, Restraints, and Opportunities of Cancer Imaging System Market
Incidence of cancer is increasing across the globe with the estimated number of cancer cases in female accounted for 2,261,419 colorectal around 865,630, lung cancer around 770, 828 in 2020. In males, lung & prostate cancer occurs in one-third of cancer cases with 1,435,943 cases of lung cancer and 1,414,259 prostate cancer across globe in 2020. These factors are likely to drive the demand for cancer imaging systems across the globe.
Artificial intelligence and nanotechnology are innovative technologies that are shaping the future of cancer imaging systems. Moreover, increasing investments and approval of new technology are estimated to propel the global market. For instance, Hologic Inc, received FDA approval of 3D imaging technology, which would enable radiologists to detect the cancer.
Increase in use of advanced imaging technology, especially for breast cancer imaging, development of healthcare infrastructure across the globe, and rise in cancer awareness are few factors that are anticipated to boosts the global market during the forecast period
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: Biospace
